TITLE

Needleless IV access device keeps pathogens out

PUB. DATE
February 2009
SOURCE
Critical Care Nurse;Feb2009, Vol. 29 Issue 1, p92
SOURCE TYPE
Academic Journal
DOC. TYPE
Product Review
ABSTRACT
The article evaluates the V-Link needleless intravenous connector from Baxter.
ACCESSION #
36381758

 

Related Articles

  • Two Lots of Baxter's GammaGard Recalled.  // BioPharm International;Jul2010, Vol. 23 Issue 7, p14 

    The article reports on the decision of Deerfield, Illinois-based pharmaceutical company Baxter BioScience Corp. to recall two lots of its GammaGard due to an increased number of adverse event reports of allergic reactions in the U.S.

  • 05 BAXTER BIOSCIENCE.  // Contract Pharma;Jul/Aug2011, Vol. 13 Issue 6, p117 

    The article profiles Deerfield, Illinois-based Baxter Bioscience Corp. which has posted a revenue increase of slightly 5.6 billion dollars in 2010. It notes that pricing pressures and market share to competitors have made it difficult to balance the supply and demand for blood protein products...

  • Bird Flu Vaccine Looks Promising. Elliott, William // Primary Care Reports;Aug2008, Vol. 14 Issue 8, p1 

    The article focuses on a study of a whole-virus vaccine developed by Baxter Bioscience that was tested on 275 volunteers between the ages of 18 and 45 years. In this study, four different strengths of the vaccine were tested with and without adjuvant. The study found that the vaccine was...

  • Bird Flu Vaccine Looks Promising.  // Primary Care Reports;Aug2008 Pharmacology Watch, p1 

    This article discusses research being done on a two dose vaccine against the avian flu. It references a study by researchers at Baxter Bioscience, published in the "New England Journal of Medicine" in 2008. The researchers have developed a whole-virus vaccine that was tested on 275 volunteers....

  • Bird Flu Vaccine Looks Promising. Elliott, William T. // Infectious Disease Alert;Aug2008, Vol. 27 Issue 11, p1 

    The article reports on a two dose vaccine that has been developed against avian flu according to a study in the "New England Journal of Medicine." The vaccine created by researchers from Baxter Bioscience was tested on 275 volunteers between the ages of 18 and 45 years. It was concluded that...

  • Bird Flu Vaccine Looks Promising.  // Neurology Alert;Aug2008 Supplement, Vol. 26, p1 

    The article discusses research being done on the effectiveness of a two dose vaccine against avian flu. It references a study by researchers from Baxter Bioscience published in a 2008 issue of the "New England Journal of Medicine." Key findings indicate that the vaccine was effective at inducing...

  • Facing Down the Enemy. Bush, Laura // BioPharm International;Jul2009, Vol. 22 Issue 7, p10 

    The author reflects on the risk of an H1N1 influenza pandemic. She stresses that people should be afraid because the threat of a flu pandemic is real and that production of a vaccine for H1N1 using egg-based manufacturing systems take 20-24 weeks. Moreover, the author praises the efforts of...

  • Baxter Brings Bravado Back To The Mix. Evans, Matthew W. // WWD: Women's Wear Daily;3/13/2009, Vol. 197 Issue 54, p13 

    The article reports that men's grooming brand Baxter of California is getting back into the fragrance game with the mid-April 2009 launch of two new scents exclusively at Barneys New York Inc. It is stated that the fragrances, called Bravado 2 and Bravado 3, play off the name of the original...

  • Process Validation Guidance-Redux. Bush, Laura // BioPharm International;Apr2009, Vol. 22 Issue 4, p10 

    The author reflects on the revised version of the process validation guidance issued by the U.S. Food and Drugs Administration for the pharmaceutical industry in the U.S. She mentions that several pharmaceutical companies such as Baxter Co., AztraZeneca Pharmaceuticals Co., and Pfizer Inc....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics